DeutschNewstral
Article
bizjournals.com on 2019-05-08 12:00
SA biotech gets FDA orphan drug designation
Related news
Sapience Therapeutics ST-36 receives orphan drug designation from FDAwestfaironline.com- MProQR shares rises on FDA orphan drug designationmarketwatch.com
- MPuma Biotech stock surges on FDA cancer drug designationmarketwatch.com
- Imbrium Therapeutics receives FDA orphan drug designation for biliary tract cancer drugwestfaironline.com
FDA Issues Draft Guidance on Orphan Drug Designation in Pediatric Subpopulationsjdsupra.com- Philadelphia gene therapy company gets FDA Orphan Drug Designation for lead product candidatebizjournals.com
- MSeres shares drop 7% after news of FDA orphan drug designation for ulcerative colitis therapymarketwatch.com
- MAkari Therapeutics shares soar 13% premarket after FDA grants Orphan Drug designation to nomacopanmarketwatch.com
- MKrystal Biotech shares up 27% after company's skin drug receives expedited review designation from FDAmarketwatch.com
Lundbeck's Carnexiv gets FDA orphan drug statusdailyherald.com- Portland biotech company gains FDA Fast Track designationbizjournals.com
FDA Approves First Generic Biotech Druglive.wsj.com
FDA approves first lower-cost biotech drugabc3340.com- FDA pilot program could help Wave avoid orphan-drug pitfallsbizjournals.com
- FDA finalizes guidance on Orphan Drug “sameness” of gene therapiesjdsupra.com
- MOrgenesis shares soar 19% premarket after FDA grants orphan designation to insulin techmarketwatch.com
- SA biotech obtains major federal drug designationbizjournals.com